China's healthcare services provider iKang Guobin Healthcare Group is aiming to raise up to $150 million in an initial public offering on the Nasdaq stock market - the latest Chinese company to attempt a listing in the US market.

The Beijing-based company reported revenue of $134 million in the 2012 fiscal year that ended in March 2013, 43 percent up year-on-year.

Its net profit rose by 25 percent year-on-year to $12 million, according to financial reports.